**Eli Lilly's $6.3 billion acquisition of a narcolepsy drug developer marks a major pharmaceutical industry merger, while the FDA is set to lift restrictions on peptides, a move influenced by RFK Jr.'s advocacy**.

• Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion — The New York Times Health -
• FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes — The New York Times Health -

A deep dive into the internet's role as a source for ultra-potent synthetic drugs highlights the growing challenges of online drug trade and overdose deaths.

• How the Internet Became the ‘Cookbook’ of the Drug Trade — The New York Times Health -

The **Supreme Court's rejection of a Colorado law banning conversion therapy for LGBTQ+ minors signals a complex legal landscape regarding ethical practices in mental health and state regulatory powers**.

• Supreme Court Rejects Colorado Law Banning ‘Conversion Therapy’ for L.G.B.T.Q. Minors — The New York Times Health -